Table 1. Studies reporting melanoma growth in patients undergoing treatment with biologics [7-13,16]

 

Authors

Biological Therapy

Number of melanoma

Journal and year

Setoguchi S et al.

Not specified

1

Arthrit & Rheum, 2006

Lebas D et al.

“TNF-alpha blockers”

1

Ann Derm Venereol, 2007

Wolfe F et al.

Infliximab

Etanercept

Adalimumab

Anakinra

11

9

1

2

Arch Rheum, 2007

Khan I et al.

Infliximab

1

Clin and Exper Dermatol, 2009

Dreyer L et al.

“TNF-alpha blockers”

3

Ugeskr Laeger, 2009

Kowalzick L et al.

Infliximab+Adalimumab+ Etanercept

1

Hautartz, 2009

Katoulis AC et al.

Adalimumab

2

Dermatology, 2010

Hacard Fet al.

Etanercept

1

Ann Derm Venereol, 2010

Manganoni AM et al.

Eculizumab

2

Ann Hematol, 2011